Recent Finacing
Recent Raise
GammaDelta Therapeutics develops γδ T cell–based immunotherapies translating King’s College London and Francis Crick Institute research into treatments for cancer and other diseases, advancing programs toward clinical evaluation.
Focus Areas
Recent Investors
Funding round
Investor